UnitedHealth Group Insider Buys Shares

On June 23, 2026, Dennis Stankiewicz, the Chief Accounting Officer of UnitedHealth Group Incorporated, purchased 51 shares of the company's stock. This insider transaction did not involve a pre-planned trading arrangement, often referred to as a Rule 10b5-1 plan.

Insider Buying and Selling at UnitedHealth Group Incorporated

In addition to Dennis Stankiewicz's purchase, several other insiders also acquired UnitedHealth Group shares on June 23, 2026. Frederick William McNabb III bought 50 shares, while Paul Garcia and Charles Baker each purchased 13 shares. Christopher Zaetta, the EVP & Chief Legal Officer, and Timothy Patrick Flynn each acquired 61 shares. Stephen Hemsley, the CEO, also bought 46 shares.

UnitedHealth Group Incorporated Stock Up 3.3%

Shares of NYSE:UNH traded near $405.80 on Friday. UnitedHealth Group is a major player in the healthcare sector with a market cap of $369.3 billion. The stock's P/E ratio stands at 30.65, with a forward P/E of 19.43, indicating market expectations for future earnings. Its 52-week range sees a low of $234.60 and a high of $415.98. The stock's 50-day moving average is $372.67, while the 200-day moving average is $333.55. UnitedHealth's beta is relatively low at 0.65, suggesting lower volatility compared to the market.

Analysts Set New Price Targets

Several analysts have maintained a 'buy' rating for UnitedHealth Group. On June 24, 2026, B of A Securities maintained its 'buy' rating with a price target of $475. Leerink Partners also maintained a 'buy' rating with a target of $462 on June 17, 2026. Other firms like Mizuho and JP Morgan have set targets at $460 and $466, respectively, with their ratings updated earlier in June 2026. Overall, the consensus among 26 analysts is a 'buy' recommendation, with an average price target of $409.77.

About UnitedHealth Group

UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through four main segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The company provides a range of healthcare services and products, including care delivery, pharmacy services, and consumer health benefit plans. UnitedHealth serves a broad spectrum of clients, from individuals and small businesses to large employers and public sector entities. The company was founded in 1974 and is led by CEO Stephen J. Hemsley.

Bottom Line

Insider buying is often seen as a positive signal, and the recent transactions at UnitedHealth Group might draw investor attention. The company's strong market position and analyst confidence, reflected in the maintained 'buy' ratings, make it a stock to watch. As always, it's important to remember that insider transactions are just one piece of the investment puzzle.